Mirtazapin Bluefish (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine, and by antagonising postsynaptic 5‑HT2 and 5‑HT3 receptors. This dual action enhances noradrenergic and serotonergic neurotransmission, leading to improved mood and reduced depressive symptoms.

The appropriate dose of Mirtazapin Bluefish is determined by the prescribing clinician based on the individual patient's condition, response, and tolerability. Dosage adjustments are made according to clinical guidelines and patient-specific factors; patients should follow the prescriber’s instructions exactly.

Safety data for mirtazapine in pregnancy and lactation are limited, and the product’s pregnancy category is listed as unknown. Healthcare providers should weigh potential benefits against risks and discuss alternative options with pregnant or nursing patients before prescribing.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mirtazapin Bluefish (mirtazapine) belongs to the NaSSA class, differing from selective serotonin reuptake inhibitors (SSRIs) by its dual noradrenergic and serotonergic activity and its antagonism of 5‑HT2/5‑HT3 receptors. This profile often results in higher sedation and appetite stimulation, which can be advantageous for patients with insomnia or weight loss.

Mirtazapin Bluefish should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency throughout its shelf life.

Mirtazapin Bluefish is taken orally, usually once daily in the evening, as directed by the prescriber. The tablet should be swallowed whole with water and not crushed or chewed unless otherwise instructed by a healthcare professional.

Serious risks include severe neutropenia, serotonin syndrome when combined with other serotonergic drugs, and marked hypotension. Patients should be monitored for signs of infection, excessive sedation, mood changes, or sudden drops in blood pressure, and any concerning symptoms should be reported promptly.

Mirtazapin Bluefish is contraindicated in patients who have known hypersensitivity to mirtazapine or any of its excipients, and it should be avoided in individuals currently taking monoamine oxidase inhibitors (MAOIs) or those with uncontrolled severe hypertension. Clinicians must assess each patient’s medical history before prescribing.